Teasing Out the Overall Survival Benefit with Adjustment for Treatment Switching to Multiple Treatments

In oncology clinical trials, characterizing the long-term overall survival (OS) benefit for an experimental treatment is often unobservable if some patients in the control group switch to drugs in ...